worth

Novo Nordisk to buy Prothena’s heart drug in deal worth up to $1.2 bln

July 12 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO) will acquire U.S. drug developer Prothena Corp's (PRTA.O) experimental heart therapy, PRX004, in a deal…

4 years ago

A $9 million boss? UniCredit investors to decide how much Orcel is worth

MILAN (Reuters) - Investors are due to approve Andrea Orcel’s appointment as chief executive of UniCredit on Thursday, but the…

5 years ago